to unravel without huge losses. So what gives. Here's my take. Hedge funds talk and often act in unisson. One of the most succesfull hedge funds is Renaissance Technologies (RT), with Co-CEO Sir Fitzhugh Brown who is married to Ms. Hamburg of the FDA. RT is successful not because of their big cap holdings but because of all the little homeruns they hit (inside information - its how its done on the street, ask Cramer). So when MNKD recieved last CRL, RT was short and profited immensly. Nice call. Also illegal, but who's watching? Apparently RT is still short, along with many hedgies, who trust Sir Fitzhugh Brown knows something. What could that be? If his firm is still short, I contend that his and Ms. Hamburg's financial welfare depend on another CRL for MNKD. Some chicken shirt phony balony reason to stretch MNKD out another two to three years. Maybe Al Mann will run out of money, maybe he will die, maybe he will just give up; who knows. There are powerfiul forces at work here, namely big pharma with much to lose with such a game changing approach to diabetes. And of course there is the run of the mill incestuous corruption of DC. Don't you just love it. So what to do. We need to know if RT is short MNKD. We need to notify SEC. We need to notify competent congressional members. If you know any , please let me know. Approval is months off - we have time""